Stay updated on Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial
Sign up to get notified when there's something new on the Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial page.

Latest updates to the Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRecruitment status now shows 'No longer looking for participants' and new help sections 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' have been added to the page. The header formatting changed from 'Intervention / Treatment' to 'Intervention/Treatment', and the revision note progressed from 'Revision: v3.5.5' to 'Revision: v3.6.0'.SummaryDifference0.5%

- Check16 days agoChange DetectedThe page's revision metadata updated from v3.5.4 to v3.5.5, signaling a platform update. This change does not alter study details, eligibility criteria, or results.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4 on the page, reflecting a version update of the page template rather than changes to the study details. No study content appears to be altered.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page footer/version indicator has been updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a site release rather than a change to the underlying study details.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check95 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial page.